Vitamin D deficiency and clinical outcomes with chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma

被引：0

作者：

Nishimura, Noriko ^{[1
]}

Flynn, Jessica ^{[2
]}

Costa, Bruno ^{[3
]}

Devlin, Sean ^{[2
]}

Farzana, Tasmin ^{[1
]}

Chung, David ^{[4
]}

Landau, Heather ^{[4
]}

Lahoud, Oscar ^{[2
]}

Scordo, Michael ^{[2
]}

Shah, Gunjan ^{[2
]}

Hassoun, Hani ^{[5
]}

Maclachlan, Kylee ^{[5
]}

Hultcrantz, Malin ^{[5
]}

Korde, Neha ^{[5
]}

Lesokhin, Alexander ^{[2
]}

Shah, Urvi ^{[5
]}

Tan, Carlyn Rose ^{[2
]}

Giralt, Sergio ^{[2
]}

Usmani, Saad ^{[2
]}

Mailankody, Sham ^{[5
]}

Nath, Karthik ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA

[2] Mem Sloan Kettering Canc Ctr, New York, NY USA

[3] Icahn Sch Med Mt Sinai, Sinai Morningside West, New York, NY 10029 USA

[4] Mem Sloan Kettering Canc Ctr, Bone Marrow Transplant & Cellular Therapy, New York, NY USA

[5] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, New York, NY USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-039

引用

页码：S55 / S56

页数：2

共 50 条

[1] Current advances in chimeric antigen receptor T-cell therapy for refractory/relapsed multiple myeloma
Huang, He
uW, Heng-wei
Hu, Yong-xian
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2020, 21 (01): : 29 - 41
[2] Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Immunoglobulin D Multiple Myeloma
Chen, Wei
Wang, Ying
Qi, Kunming
Shi, Ming
Cao, Jiang
Bhansali, Rahul
Wang, Xue
Liu, Yang
Li, Hujun
Zhang, Huanxin
Yan, Zhiling
Sang, Wei
Cheng, Hai
Zhu, Feng
Sun, Haiying
Li, Depeng
Jing, Guangjun
Zheng, Junnian
Li, Zhenyu
Xu, Kailin
TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (03): : 273.e1 - 273.e5
[3] Safety and efficacy of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma with renal impairment
Hujun Li
Lingling Yin
Ying Wang
Xiangmin Wang
Ming Shi
Jiang Cao
Zhiling Yan
Wei Sang
Hai Cheng
Feng Zhu
Haiying Sun
Depeng Li
Guangjun Jing
Junnian Zheng
Zhenyu Li
Kailin Xu
Bone Marrow Transplantation, 2020, 55 : 2215 - 2218
[4] Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment
Sidana, Surbhi
Peres, Lauren C.
Hashmi, Hamza
Hosoya, Hitomi
Ferreri, Christopher
Khouri, Jack
Dima, Danai
Atrash, Shebli
Voorhees, Peter
Simmons, Gary
Sborov, Douglas W.
Kalariya, Nilesh
Hovanky, Vanna
Bharadwaj, Sushma
Miklos, David
Wagner, Charlotte
Kocoglu, Mehmet H.
Kaur, Gurbakhash
Davis, James A.
Midha, Shonali
Janakiram, Murali
Freeman, Ciara
Alsina, Melissa
Locke, Frederick
Gonzalez, Rebecca
Lin, Yi
Mcguirk, Joseph
Afrough, Aimaz
Shune, Leyla
Patel, Krina K.
Hansen, Doris K.
HAEMATOLOGICA, 2024, 109 (03) : 777 - 786
[5] Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: A Real-World Experience
Lal, Bhavesh Mohan
Pandey, Toshali
Alzubi, Marah
Alrawabdeh, Jawad
Shaughnessy Jr, John D.
Zhan, Fenghuang
Siegel, Eric
Schinke, Carolina
Thanendrarajan, Sharmilan
Zangari, Maurizio
van Rhee, Frits
Al Hadidi, Samer
BLOOD, 2024, 144 : 2405 - 2406
[6] Safety and efficacy of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma with renal impairment
Li, Hujun
Yin, Lingling
Wang, Ying
Wang, Xiangmin
Shi, Ming
Cao, Jiang
Yan, Zhiling
Sang, Wei
Cheng, Hai
Zhu, Feng
Sun, Haiying
Li, Depeng
Jing, Guangjun
Zheng, Junnian
Li, Zhenyu
Xu, Kailin
BONE MARROW TRANSPLANTATION, 2020, 55 (11) : 2215 - 2218
[7] Impact of Prior Selinexor Exposure on Outcomes of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Exploratory Analysis
Costa, Bruno Almeida
Dima, Danai
Mark, Tomer
Sadek, Norah Layla
Ijioma, Stephen
Ray, David
Goel, Utkarsh
Dranitsaris, George
Sheng, Tianxiang
Moshier, Erin
Mouhieddine, Tarek H.
Khouri, Jack
Rossi, Adriana
JOURNAL OF CLINICAL MEDICINE, 2025, 14 (04)
[8] Impact of Frailty on Outcomes after Chimeric Antigen Receptor T Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma
Davis, James A.
Dima, Danai
Ahmed, Nausheen
Dejarnette, Shaun
McGuirk, Joseph
Jia, Xuefei
Raza, Shahzad
Khouri, Jack
Valent, Jason
Anwer, Faiz
Abdallah, Al-Ola
Hashmi, Hamza
TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (03): : 298 - 305
[9] Chimeric antigen receptor T-cell therapy for multiple myeloma
Wang, Zehua
Chen, Chen
Wang, Lei
Jia, Yongxu
Qin, Yanru
FRONTIERS IN IMMUNOLOGY, 2022, 13
[10] Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma
Hosen, Naoki
CANCERS, 2019, 11 (12)

← 1 2 3 4 5 →